Kanisa Pharmaceuticals
2 clinical trials · Sponsor
◉ Watch Kanisa Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia (NCT00233909) | Kanisa Pharmaceuticals | 2005-10-01 |
| Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML) (NCT00129168) | Kanisa Pharmaceuticals | 2005-08-01 |
Track Kanisa Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.